Prescription status of edaravone and personal importation: Notice of update
Description
Organizations and the provinces/territories continue to make progress in the marketing and reimbursement of edaravone (brand name Radicava). Currently, all provinces with the exception of Prince Edward Island (PEI) have updated their drug formularies to include edaravone for public reimbursement. The territories are still in the process of establishing full coverage.
Resources
| Name |
Format |
Description |
Link |
| Prescription status of edaravone and personal importation: Notice of update |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/importation-exportation/prescription-edaravone-importation-notice.html |
| Prescription status of edaravone and personal importation: Notice of update |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/importation-exportation/ordonnance-edaravone-importation-avis.html |